The gross margin collapse in Q2 2026 is an outlier, as the trailing four quarters averaged around 20% gross margin, suggesting a one-time write-down. However, even excluding that quarter, operating margins have been thin, ranging from -11.2% to 6.5% over the past year, indicating persistent negative operating leverage. The company's high fixed-cost structure and cyclical end-markets mean that any volume shortfall quickly erodes profitability, as seen in the -130.5% operating margin in Q2 2026. Investors should monitor whether the company can return to positive operating margins in the low-single digits, which would still be insufficient to cover interest expenses given the elevated debt load.

Over the last ten quarters, ROIC has been consistently below 2% except for a few quarters, and the latest quarter's -19.5% is a stark outlier. This suggests that the company is not generating returns above its cost of capital, which is likely elevated given the high leverage. The impairment in Q2 2026 reduced the capital base, but the underlying operational returns remain weak, as evidenced by the negative net margins. The company's ability to compound returns is questionable, and the market's EV/EBITDA of 45x appears to price in a recovery that is not yet visible in the return metrics.

The sharp increase in DSO from around 60 days to 154 days in Q2 2026 is a red flag, as it may indicate that the company is extending payment terms to customers to support volumes, or that there are disputes over billed amounts. DIO and DPO remained relatively stable, so the elongation is primarily from receivables. This suggests deteriorating working capital efficiency, which is particularly concerning given the negative cash flow from operations. Asset turnover also fell to 0.11x in Q2 2026 from 0.33x in Q1, reflecting the revenue decline and the asset write-downs. The company needs to tighten credit terms and improve collection to free up cash.

The dramatic increase in leverage is partly due to the equity swing from a $1.3B change, which included a large impairment and a possible equity infusion. However, the absolute debt level of $422M remains high relative to the company's market cap and cash flows. Interest coverage has been negative for most of the past year, with only a few quarters of positive coverage, suggesting that the company is reliant on external financing to service debt. The high leverage restricts financial flexibility and increases refinancing risk, especially in a high-interest-rate environment. Investors should monitor the company's ability to refinance upcoming maturities and whether it can generate sufficient EBITDA to cover interest expenses.

The current ratio of 1.43 is above 1, but the quick ratio of 1.19 shows that the company relies on inventory to meet short-term obligations, which may be difficult to liquidate in a downturn. The cash balance increased to $253.4M, likely from a capital raise or asset sales, but the operating cash flow of -$296.9M in Q2 2026 indicates that the company is burning cash at an alarming rate. Even if the impairment is non-cash, the underlying operations are not generating sufficient cash to cover working capital needs and capital expenditures. The company's liquidity position would be severely tested if revenue continues to decline and access to credit markets tightens.